Replies to post #76814 on Ariad Pharmaceuticals Inc fka ARIA

[lax20m]

I don't understand how approval in Japan in this indication helps the possibility of moving to 2nd line. Please explain your logic. I certainly ascribe no weight from today's approval to 2nd line useage and even if I did would have ascribed the same amount yesterday as I was fully expecting approval.